Latest filing published 15 Apr 2024 for Netramark Holdings Inc. (formerly Nurosene Health Inc.), €12k.
Andrew Parks discloses dealings in Netramark Holdings Inc. (formerly Nurosene Health Inc.) to SEDI. The record holds 6 filings, for trades running from 25 May 2021 to 12 April 2024.
The open-market record is one-sided, with 2 purchases worth €22k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant and 2 option exercises. Since January 2024: 2 purchases and no sales on the market.
The newest entry dates from 15 April 2024: an open-market purchase of €12k, in Netramark Holdings Inc. (formerly Nurosene Health Inc.). Typically, a trade is published a median of 3 days after it takes place. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations